MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 421 filers reported holding MEDIVATION INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $12,874,000 | +1933.8% | 213,500 | +1529.8% | 0.60% | +1478.9% |
| Q4 2015 | $633,000 | -67.7% | 13,100 | -13.8% | 0.04% | -79.8% |
| Q1 2015 | $1,961,000 | +84.1% | 15,200 | +42.1% | 0.19% | +14.6% |
| Q4 2014 | $1,065,000 | +369.2% | 10,700 | +365.2% | 0.16% | +272.7% |
| Q3 2014 | $227,000 | -85.4% | 2,300 | -90.5% | 0.04% | -40.5% |
| Q1 2014 | $1,557,000 | +213.3% | 24,200 | +210.3% | 0.07% | +54.2% |
| Q4 2013 | $497,000 | – | 7,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |